Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System

  • Discussing the importance of tumor antigen selection and balanced immunity in vaccine design
  • Addressing the tumor microenvironment to enhance cancer vaccines